Summary
Isolated rabbit hearts were perfused with Ca2+-free solution containing 139.7 mM K+ and 12.3 mM Na+ (Tyrode solution modified by omission of CaCl2 and substitution of NaCl by KCl). The noradrenaline in the perfusate was determined spectrofluorimetrically. Perfusion with this solution induced release of noradrenaline, and introduction of 1.8 mM CaCl2 for 2 min after perfusion with the Ca2+-free solution evoked additional release.
-
1.
Methacholine (10−4M) and oxymetazoline (3.8×10−7M) decreased, whereas angiotensin II (10−9M) increased, the noradrenaline release evoked by 1.8 mM CaCl2.
-
2.
The changes of CaCl2-induced noradrenaline release caused by these drugs were abolished by the corresponding antagonists (atropine, 3.5×10−6M; phentolamine, 10−6M, and Sar1, Ile8-angiotensin II, 10−9M, respectively). When given alone, phentolamine (10−6M) increased, whereas atropine (3.5×10−6M) and Sar1, Ile8-angiotensin II (10−9M) did not significantly alter the noradrenaline release evoked by 1.8 mM CaCl2.
-
3.
The noradrenaline release induced by perfusion of the heart with the Ca2+-free solution containing a low Na+ and a high K+ concentration was not affected by any of the drugs.
These findings provide additional evidence for the suggestion that modulation of noradrenaline release induced by activation of presynaptic muscarine, α-adrenergic, and angiotensin receptors is mediated via changes in the availability of Ca2+ ions for stimulus-release coupling.
Similar content being viewed by others
References
Dubey, M. P., Muscholl, E., Pfeiffer, A.: Muscarinic inhibition of potassium-induced noradrenaline release and its dependence on the calcium concentration. Naunyn-Schmiedeberg's Arch. Pharmacol. 291, 1–15 (1975)
Endo, T., Starke, K., Bangerter, A., Taube, H. D.: Presynaptic receptor systems on the noradrenergic neurones of the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch. Pharmacol. 296, 229–247 (1977)
Fleckenstein, A.: Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lestons. In: Calcium and the Heart (P. Harris and L. H. Opie, eds.), pp. 135–188. New York: Academic Press 1971
Garcia, A. G., Kirpekar, S. M.: Release of noradrenaline from the cat spleen by sodium deprivation. Br. J. Pharmacol. 47, 729–747 (1973)
Gerhards, K. P., Röttcher, M., Straub, R. W.: Wirkung von Ca und Mg auf Freisetzung und Synthese von Acetylcholin am ruhiggestellten Darm. Pflügers Arch. ges. Physiol. 279, 251–264 (1964)
Göthert, M.: Effects of halothane on the sympathetic nerve terminals of the rabbit heart. Differences in membrane actions of halothane and tetracaine. Naunyn-Schmiedeberg's Arch. Pharmacol. 286, 125–143 (1974)
Göthert, M., Neumeyer, H.: Noradrenaline release from cardiac sympathetic nerves induced by Ca2+-dependent stimulation methods or by external Ca2+ itself: effects of Ca2+ antagonists, tetracaine and drugs modulating release. Naunyn-Schmiedeberg's Arch. Pharmacol. 297, R49 (1977)
Göthert, M., Kennerknecht, E., Thielecke, G.: Inhibition of receptor-mediated noradrenaline release from the sympathetic nerves of the isolated rabbit heart by anesthetics and alcohols in proportion to their hydrophobic property. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 145–152 (1976)
Hedqvist, P.: Antagonism by calcium of the inhibitory action of prostaglandin E2 on sympathetic neurotransmission in the cat spleen. Acta Physiol. Scand. 80, 269–275 (1970)
Kohlhardt, M., Bauer, B., Krause, H., Fleckenstein, A.: Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibers by the use of specific inhibitors. Pflügers Arch. 335, 309–322 (1972)
Löffelholz, K.: Untersuchungen über die Noradrenalin-Freisetzung durch Acetylcholin am perfundierten Kaninchenherzen. Naunyn-Schmiedeberg's Arch. Pharmak. exp. Path. 258, 108–122 (1967)
Löffelholz, K., Muscholl, E.: A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation. Naunyn-Schmiedeberg's Arch. Pharmak. 265, 1–15 (1969)
Muscholl, E.: Regulation of catecholamine release. The muscarinic inhibitory mechanism. In: Frontiers in Catecholamine Research, (Usdin, E., and Snyder, S. H., eds.) pp. 537–542. New York: Pergamon Press 1973
Muscholl, E., Ritzel, H., Rössler, K.: The time course of noradrenaline release caused by high potassium-low sodium solution. Effects of methacholine or decrease of the calcium ion concentration. Br. J. Pharmacol. 55, 248P (1975)
Ritzel, H., Muscholl, E.: Differences in time course and Ca2+-dependency of noradrenaline (NA) release from the heart evoked by high K+ and/or low Na+ solutions. Naunyn-Schmiedeberg's Arch. Pharmacol. 293, R2 (1976)
Smith, A. D., Winkler, H.: Fundamental mechanisms in the release of catecholamines. In: Handbook of experimental Pharmacology, Vol. XXXIII, (Blaschko, H. and Muscholl, E., eds.), pp. 538–617. Berlin-Heidelberg-New York: Springer 1972
Starke, K.: Action of angiotensin on uptake, release and metabolism of 14C-noradrenaline by isolated rabbit hearts. Eur. J. Pharmacol. 14, 112–123 (1971)
Starke, K.: Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 18–45 (1972)
Starke, K.: Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77, 1–124 (1977)
Starke, K., Montel, H.: Influence of drugs with affinity for α-adrenoceptors on noradrenaline release by potassium tyramine and dimethylphenylpiperazinum. Eur. J. Pharmacol. 27, 273–280 (1974)
Starke, K., Werner, U., Schümann, H. J.: Wirkung von Angiotensin auf Funktion und Noradrenalinabgabe isolierter Kaninchenherzen in Ruhe und bei Sympathicusreizung. Naunyn-Schmiedeberg's Arch. Pharmak. 265, 170–186 (1969)
Stjärne, L.: Comparison of secretion of sympathetic neurotransmitter induced by nerve stimulation with that evoked by high potassium, as triggers of dual alpha-adrenoceptor mediated negative feed-back control of noradrenaline secretion. Prostaglandins 3, 105–109 (1973)
Vincenzi, F. F., West, T. C.: Modification by calcium of the release of autonomic mediators on the isolated sino-atrial node. J. Pharmacol. Exp. Ther. 150, 349–360 (1965)
Watanabe, A. M., Besch, H. R., jr.: Subcellular myocardial effects of verapamil and D 600: comparison with propranolol. J. Pharmacol. Exp. Ther. 191, 241–251 (1974)
Westfall, T. C., Brasted, M.: Specificity of blockade of the nicotine-induced release of 3H-norepinephrine from adrenergic neurons of the guinea-pig heart by various pharmacological agents. J. Pharmacol. Exp. Ther. 189, 659–664 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Göthert, M. Effects of presynaptic modulators on Ca2+-induced noradrenaline relase from cardiac sympathetic nerves. Naunyn-Schmiedeberg's Arch. Pharmacol. 300, 267–272 (1977). https://doi.org/10.1007/BF00500969
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00500969